BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35121582)

  • 1. The COX-2-PGE2 Pathway Promotes Tumor Evasion in Colorectal Adenomas.
    Wei J; Zhang J; Wang D; Cen B; Lang JD; DuBois RN
    Cancer Prev Res (Phila); 2022 May; 15(5):285-296. PubMed ID: 35121582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells.
    Hsu HH; Lin YM; Shen CY; Shibu MA; Li SY; Chang SH; Lin CC; Chen RJ; Viswanadha VP; Shih HN; Huang CY
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesis.
    Chang J; Vacher J; Yao B; Fan X; Zhang B; Harris RC; Zhang MZ
    Oncotarget; 2015 Oct; 6(32):33500-11. PubMed ID: 26378024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells.
    Nandi P; Girish GV; Majumder M; Xin X; Tutunea-Fatan E; Lala PK
    BMC Cancer; 2017 Jan; 17(1):11. PubMed ID: 28056899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cordycepin inhibits lipopolysaccharide-induced cell migration and invasion in human colorectal carcinoma HCT-116 cells through down-regulation of prostaglandin E2 receptor EP4.
    Jeong JW; Park C; Cha HJ; Hong SH; Park SH; Kim GY; Kim WJ; Kim CH; Song KS; Choi YH
    BMB Rep; 2018 Oct; 51(10):532-537. PubMed ID: 30269738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of COX-2/PGE2/EP4 Axis-induced Macrophage Functional Activation 
in NSCLC Development].
    Zhao J; Zhu Q; Zhang Y; Li G; Zhang Y; Li F; Bian L
    Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):245-256. PubMed ID: 38769827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP‑PKA/PI3K‑Akt signaling pathway.
    Xu S; Zhou W; Ge J; Zhang Z
    Mol Med Rep; 2018 Mar; 17(3):4702-4712. PubMed ID: 29328471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs.
    Al-Kharusi MR; Smartt HJ; Greenhough A; Collard TJ; Emery ED; Williams AC; Paraskeva C
    Carcinogenesis; 2013 May; 34(5):1150-7. PubMed ID: 23349017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation.
    Majumder M; Landman E; Liu L; Hess D; Lala PK
    Mol Cancer Res; 2015 Jun; 13(6):1022-33. PubMed ID: 25733698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer.
    Doherty GA; Byrne SM; Molloy ES; Malhotra V; Austin SC; Kay EW; Murray FE; Fitzgerald DJ
    BMC Cancer; 2009 Jun; 9():207. PubMed ID: 19558693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of EP
    Wang Y; Cui L; Georgiev P; Singh L; Zheng Y; Yu Y; Grein J; Zhang C; Muise ES; Sloman DL; Ferguson H; Yu H; Pierre CS; Dakle PJ; Pucci V; Baker J; Loboda A; Linn D; Brynczka C; Wilson D; Haines BB; Long B; Wnek R; Sadekova S; Rosenzweig M; Haidle A; Han Y; Ranganath SH
    Oncoimmunology; 2021 Mar; 10(1):1896643. PubMed ID: 33796403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cyclooxygenase-2 expression by prostaglandin E2 stimulation of the prostanoid EP4 receptor via coupling to Gαi and transactivation of the epidermal growth factor receptor in HCA-7 human colon cancer cells.
    Yoshida K; Fujino H; Otake S; Seira N; Regan JW; Murayama T
    Eur J Pharmacol; 2013 Oct; 718(1-3):408-17. PubMed ID: 23973650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model.
    Parida S; Parekh A; Dey G; Ghosh SC; Mandal M
    Cancer Biol Ther; 2015; 16(6):922-32. PubMed ID: 25894216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition.
    Lu JW; Wang WS; Zhou Q; Gan XW; Myatt L; Sun K
    FASEB J; 2019 Jul; 33(7):8148-8160. PubMed ID: 30917001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis.
    Majumder M; Xin X; Liu L; Tutunea-Fatan E; Rodriguez-Torres M; Vincent K; Postovit LM; Hess D; Lala PK
    Stem Cells; 2016 Sep; 34(9):2290-305. PubMed ID: 27301070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
    Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
    Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EP4 receptor as a novel promising therapeutic target in colon cancer.
    Karpisheh V; Joshi N; Zekiy AO; Beyzai B; Hojjat-Farsangi M; Namdar A; Edalati M; Jadidi-Niaragh F
    Pathol Res Pract; 2020 Dec; 216(12):153247. PubMed ID: 33190014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E Receptor 4 Antagonist in Cancer Immunotherapy: Mechanisms of Action.
    Take Y; Koizumi S; Nagahisa A
    Front Immunol; 2020; 11():324. PubMed ID: 32210957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway.
    Vo BT; Morton D; Komaragiri S; Millena AC; Leath C; Khan SA
    Endocrinology; 2013 May; 154(5):1768-79. PubMed ID: 23515290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.